01 5Kineret
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 157
2018 Revenue in Millions : 132
Growth (%) : 19
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 249
2019 Revenue in Millions : 188
Growth (%) : 32
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 246
2020 Revenue in Millions : 229
Growth (%) : 10
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 215
2021 Revenue in Millions : 246
Growth (%) : -13
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 232
2022 Revenue in Millions : 215
Growth (%) : 6
